Location History:
- Knivsta, SE (2006 - 2011)
- Margaretavägen, SE (2014)
Company Filing History:
Years Active: 2006-2014
Title: Håkan Engqvist: Innovator in Drug Delivery Systems
Introduction
Håkan Engqvist is a distinguished inventor based in Knivsta, Sweden. With a portfolio of five patents, Engqvist has made significant contributions to the fields of drug delivery and dental materials. His innovations demonstrate a commitment to improving medical technologies that enhance patient care.
Latest Patents
Engqvist's latest patents include a pioneering drug implant carrier designed for efficient drug delivery. This invention utilizes a ceramic precursor material that exhibits injectability, making it suitable as a carrier material for anti-infective and anti-inflammatory drugs. The microstructure developed in this invention is based on pre-reacted phases, facilitating a tailored approach to drug delivery within orthopedic applications and the treatment of bone voids.
Another notable patent involves a dental cement system comprising a powdered material and a hydration liquid. The innovative cement is formulated to create complex chemically bonded materials, which are effective for cementing implants to other implants or dental tissues, showcasing Engqvist's expertise in biocompatible materials.
Career Highlights
Håkan Engqvist currently works at Doxa AB, where he continues to drive forward advancements in medical materials and applications. His work is characterized by a blend of scientific research and practical implementation, making significant impacts in both research circles and clinical settings.
Collaborations
Engqvist collaborates with notable colleagues, including Leif Hermansson and Jesper Lööf, fostering a teamwork environment that encourages innovation and the exchange of ideas. Their combined expertise further enhances the development of groundbreaking technologies in their field.
Conclusion
Håkan Engqvist is a remarkable inventor whose contributions to drug delivery systems and dental materials have the potential to transform patient treatment options. Through his innovative patents and collaborative efforts, he continues to be a driving force in medical technology advancements at Doxa AB.